Mark Worthington - GENERAL COUNSEL at Athira Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
ATHA on Nasdaq
All Insider Reports
All Insider Reports

Mark Worthington - trading volume in the past year for Athira Pharma, Inc.

Holdings reported by Mark Worthington for Athira Pharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 34.5K $100K $2.91 Jan 5, 2024 Direct
Stock Option (Right to Buy) 220K Feb 14, 2024 Direct Common Stock

Transactions reported by Mark Worthington for Athira Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.